Cargando…

Association of Diabetes Mellitus Status and Glycemic Control With Secondary Prevention Medication Adherence After Acute Myocardial Infarction

BACKGROUND: Cardioprotective medication adherence can mitigate the risk of recurrent cardiovascular events and mortality after acute myocardial infarction (AMI). We examined the associations of diabetes mellitus status and glycemic control with cardioprotective medication adherence after AMI. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adamek, Kylie E., Ramadurai, Deepa, Gunzburger, Elise, Plomondon, Mary E., Ho, P. Michael, Raghavan, Sridharan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405589/ https://www.ncbi.nlm.nih.gov/pubmed/30712488 http://dx.doi.org/10.1161/JAHA.118.011448

Ejemplares similares

Cumulative Adherence to Secondary Prevention Guidelines and Mortality After Acute Myocardial Infarction
por: Solomon, Matthew D., et al.
Publicado: (2020)

Long-term secondary prevention of acute myocardial infarction (SEPAT) – guidelines adherence and outcome
por: Ergatoudes, Constantinos, et al.
Publicado: (2016)

Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction
por: Halvorsen, Sigrun, et al.
Publicado: (2016)

Endobronchial valve placement in secondary pneumothorax related to allergic bronchopulmonary aspergillosis
por: Ramadurai, Deepa, et al.
Publicado: (2021)

Use of secondary prevention pharmacotherapy after first myocardial infarction in patients with diabetes mellitus
por: Jørgensen, Casper H, et al.
Publicado: (2014)

Glycemic variability is associated with myocardial damage in nondiabetic patients with ST-elevation myocardial infarction
por: Oka, Satoshi, et al.
Publicado: (2018)

Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
por: Li, Yan, et al.
Publicado: (2020)

Effect of Intensive Glycemic Control on Myocardial Infarction Outcome in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: He, Jiading, et al.
Publicado: (2023)

Painless acute myocardial infarction and diabetes mellitus
por: Grmec, Š
Publicado: (1998)

Self‐Controlled Case‐Series Study to Verify the Effect of Adherence to Beta‐Blockers in Secondary Prevention of Myocardial Infarction
por: Di Bartolomeo, Stefano, et al.
Publicado: (2015)

Association of lipocalin-2 level, glycemic status and obesity in type 2 diabetes mellitus
por: Elkhidir, Areej E., et al.
Publicado: (2017)

Repetitive Myocardial Infarctions Secondary to Delirium Tremens
por: Schwartzberg, David, et al.
Publicado: (2014)

Acute Myocardial Infarction Secondary to Paradoxical Embolism
por: Alenezi, Abdullah R, et al.
Publicado: (2020)

Glycemic control and adherence to basal insulin therapy in Taiwanese patients with type 2 diabetes mellitus
por: Chien, Ming‐Nan, et al.
Publicado: (2016)

Prognostic value of early in-hospital glycemic excursion in elderly patients with acute myocardial infarction
por: Su, Gong, et al.
Publicado: (2013)

An Elevated Glycemic Gap is Associated with Adverse Outcomes in Diabetic Patients with Acute Myocardial Infarction
por: Liao, Wen-I, et al.
Publicado: (2016)

Prognostic Value of the Leuko-Glycemic Index in Acute Myocardial Infarction Patients with or without Diabetes
por: Qi, Ling-Yao, et al.
Publicado: (2022)

Adherence to treatment assessed with the Adherence in Chronic Diseases Scale in patients after myocardial infarction
por: Kosobucka, Agata, et al.
Publicado: (2018)

Diagnosing Medication Non-Adherence in a Patient with Myocardial Infarction
por: Ye, Siqin, et al.
Publicado: (2012)

Medication adherence and its determinants in patients after myocardial infarction
por: Pietrzykowski, Łukasz, et al.
Publicado: (2020)

Association of Glycemic Status with Bone Turnover Markers in Type 2 Diabetes Mellitus
por: Kulkarni, Sweta Vilas, et al.
Publicado: (2017)

Association of Socioeconomic Status With Risk Factor Target Achievements and Use of Secondary Prevention After Myocardial Infarction
por: Ohm, Joel, et al.
Publicado: (2021)

Survival of Myocardial Infarction Patients with Diabetes Mellitus at the Invasive Era (Results from the Városmajor Myocardial Infarction Registry)
por: Skoda, Réka, et al.
Publicado: (2023)

The impact of time-window bias on the assessment of the long-term effect of medication adherence: the case of secondary prevention after myocardial infarction
por: Di Martino, Mirko, et al.
Publicado: (2015)

Effects of adherence to pharmacological secondary prevention after acute myocardial infarction on health care costs – an analysis of real-world data
por: Kirsch, Florian, et al.
Publicado: (2020)

Association of diabetes mellitus and glycemic control with left ventricular function and deformation in patients after acute myocardial infarction: a 3 T cardiac magnetic resonance study
por: Gao, Yue, et al.
Publicado: (2023)

Secondary Prevention of Myocardial Infarction With Nonpharmacologic Strategies in a Medicaid Cohort
por: Oberg, Erica B., et al.
Publicado: (2009)

The reliability of in-hospital diagnoses of diabetes mellitus in the setting of an acute myocardial infarction
por: Arnold, Suzanne V, et al.
Publicado: (2014)

Quality of glycemic control has significant impact on myocardial mechanics in type 1 diabetes mellitus
por: Hajdu, Máté, et al.
Publicado: (2022)

Current status of acute myocardial infarction in Korea
por: Kim, Yongcheol, et al.
Publicado: (2019)

Patient Adherence to Therapy After Myocardial Infarction: A Scoping Review
por: Zorina, Olga, et al.
Publicado: (2022)

A hospital-based assessment of glycemic control and medication adherence in type 2 diabetes mellitus in Eastern Nepal
por: Sarraf, Deependra Prasad, et al.
Publicado: (2023)

Vitamin D Deficiency and Glycemic Status in Children and Adolescents with Type 1 Diabetes Mellitus
por: Savastio, Silvia, et al.
Publicado: (2016)

Association between glycemic status and thyroid dysfunction in patients with type 2 diabetes mellitus
por: Ogbonna, SU, et al.
Publicado: (2019)

Prognostic Value of The Leuko-Glycemic Index in Acute Myocardial Infarction; a Systematic Review and Meta-Analysis
por: Sadeghi, Roxana, et al.
Publicado: (2023)

Difference in Medication Adherence Between Patients Prescribed a 30‐Day Versus 90‐Day Supply After Acute Myocardial Infarction
por: Rymer, Jennifer A., et al.
Publicado: (2020)

Moderate- to high-intensity statins for secondary prevention in patients with type 2 diabetes mellitus on dialysis after acute myocardial infarction
por: Li, Yan-Rong, et al.
Publicado: (2017)

Secondary Prevention of Myocardial Infarction in People Living With HIV Infection
por: Erqou, Sebhat, et al.
Publicado: (2020)

Acute myocardial infarction secondary to mucormycosis after lung transplantation
por: Naik, Chetan A., et al.
Publicado: (2020)

ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION SECONDARY TO COVID-19
por: DOUEDI, STEVEN, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mqtnrk6p1g5b7k7k2jeu8f9tmk